PRIMARY STUDY

Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk

Key Findings:  Subjects who were informed of an increased predisposition to schizophrenia with the use of marijuana reported their likelihood and the importance of avoiding marijuana as significantly higher, especially with a past history of use.

Type of Study:  Clinical Trial

Study Sample Size:  1601

Study Result:  Positive

Research Location(s):  United States

Year of Pub:  2021


Cannabinoids Studied: 

Phytocannabinoid Source:  Not Applicable




Citation:  Lebowitz MS, et al. Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk. J Psychiatr Res. 2021; 140:316-322. doi: 10.1016/j.jpsychires.2021.05.066

Authors:  Lebowitz MS, Appelbaum PS, Dixon LB, Girgis RR, Wall MM